Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
Obstetrics and Gynecology
|
May 2, 2007
Clinical and pathologic correlates in surgical stage II endometrial carcinoma
David E Cohn, Emily M Woeste, Stacey Cacchio, et al.
Surgical Oncology
|
September 6, 2020
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations
David A Barrington, Ashley S Felix, Rieham Owda, et al.
American Journal of Obstetrics and Gynecology
|
August 5, 2022
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancer
Michelle D S Lightfoot, Ashley S Felix, Corinne A Calo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2009
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors
Pravin T P Kaumaya, Kevin Chu Foy, Joan Garrett, et al.
Gynecologic Oncology
|
July 16, 2017
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival
Casey M Cosgrove, David E Cohn, Heather Hampel, et al.
Gynecologic Oncology
|
December 14, 2021
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study
Ursula A Matulonis, Helen Q Huang, Virginia L Filiaci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2009
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup
Michael A Bookman, Mark F Brady, William P McGuire, et al.
Gynecologic Oncology
|
November 28, 2017
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study
Neil S Horowitz, G Larry Maxwell, Austin Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2012
Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study
Charles F Levenback, Shamshad Ali, Robert L Coleman, et al.
Gynecologic Oncology
|
December 4, 2012
Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173
Robert L Coleman, Shamshad Ali, Charles F Levenback, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
Obstetrics and Gynecology
|
May 2, 2007
Clinical and pathologic correlates in surgical stage II endometrial carcinoma
David E Cohn, Emily M Woeste, Stacey Cacchio, et al.
Surgical Oncology
|
September 6, 2020
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations
David A Barrington, Ashley S Felix, Rieham Owda, et al.
American Journal of Obstetrics and Gynecology
|
August 5, 2022
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancer
Michelle D S Lightfoot, Ashley S Felix, Corinne A Calo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2009
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors
Pravin T P Kaumaya, Kevin Chu Foy, Joan Garrett, et al.
Gynecologic Oncology
|
July 16, 2017
Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival
Casey M Cosgrove, David E Cohn, Heather Hampel, et al.
Gynecologic Oncology
|
December 14, 2021
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study
Ursula A Matulonis, Helen Q Huang, Virginia L Filiaci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2009
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup
Michael A Bookman, Mark F Brady, William P McGuire, et al.
Gynecologic Oncology
|
November 28, 2017
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study
Neil S Horowitz, G Larry Maxwell, Austin Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2012
Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study
Charles F Levenback, Shamshad Ali, Robert L Coleman, et al.
Gynecologic Oncology
|
December 4, 2012
Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173
Robert L Coleman, Shamshad Ali, Charles F Levenback, et al.
Page
of 11